Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLI vs GSK✓SelectedUSD · GSKXLI vs GSK performance historyLatest closeAs of-0.39%11/13
Stock and ETF performance explorer

XLI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,075.5%
GSK return
+159.5%
Excess return
+916.0%
Maximum drawdown
-62.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.4%+0.5%-0.9%-0.6%
7D+3.8%+1.1%+2.6%+3.3%
30D+1.0%+6.3%-5.3%-1.4%
3M-8.9%+1.8%-10.7%-10.0%
6M-2.3%+1.7%-3.9%-3.7%
YTD+9.7%+6.5%+3.1%+5.6%
1Y+12.3%+9.5%+2.8%+7.0%
3Y+71.5%+65.3%+6.2%+35.2%
5Y+70.2%+43.7%+26.4%+39.2%
10Y+227.5%+104.1%+123.3%+128.7%
All+1,075.5%+159.5%+916.0%+557.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling